enGene Holdings Inc. (the “Issuer”)
| (b) | Address of Issuer’s Principal Executive Offices: |
7171 Rue Frederick Banting
Saint-Laurent, QC, Canada H4S 1Z9
(a) – (c) Name of Persons Filing; Address; Citizenship:
(i) Forbion Capital Fund III Coöperatief U.A, a cooperative association with exempted liability incorporated in the Netherlands (“Forbion III COOP”).
(ii) Forbion III Management B.V., a private limited liability company incorporated in the Netherlands (“Forbion III”), the director of Forbion III COOP.
The address of the principal business office of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer 2-35, 1411 DC Naarden, The Netherlands.
| (d) | Title of Class of Securities: |
Class A common shares
29286M105
Item 3. | If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
(a) and (b) Amount beneficially owned:
The information set forth in rows 5 through 11 of the cover pages is incorporated by reference into this Item 4.
The percent of class is based upon (i) 23,197,976 Class A common shares outstanding, as reported by the Issuer in its Current Report on Form 8-K filed with the Securities and Exchange Commission on October 31, 2023, plus (ii) 475,076 Class A common shares underlying warrants exercisable within 60 days.
| (c) | Number of shares as to which such person has: |
| | | | | | | | | | | | | | | | | | | | |
Reporting Person | | Sole Voting Power | | | Shared Voting Power | | | Sole Dispositive Power | | | Shared Dispositive Power | | | Percentage of Common Stock Outstanding | |
Forbion III COOP | | | 3,369,275 | | | | 0 | | | | 3,369,275 | | | | 0 | | | | 14.2 | % |
Forbion III | | | 3,369,275 | | | | 0 | | | | 3,369,275 | | | | 0 | | | | 14.2 | % |